Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 5.35142137 |
2 | proteasome assembly (GO:0043248) | 5.13112969 |
3 | protein neddylation (GO:0045116) | 4.53635654 |
4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.51850128 |
5 | DNA deamination (GO:0045006) | 4.40839163 |
6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.35940723 |
7 | ATP synthesis coupled proton transport (GO:0015986) | 4.35940723 |
8 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.33014974 |
9 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.25467313 |
10 | termination of RNA polymerase III transcription (GO:0006386) | 4.25467313 |
11 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.12473891 |
12 | chaperone-mediated protein transport (GO:0072321) | 4.10209491 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 4.08104552 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 4.00189380 |
15 | establishment of integrated proviral latency (GO:0075713) | 3.99949471 |
16 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.99491050 |
17 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.98367294 |
18 | negative regulation of ligase activity (GO:0051352) | 3.94186262 |
19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.94186262 |
20 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.90107298 |
21 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.87555740 |
22 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.85931839 |
23 | ribosomal small subunit assembly (GO:0000028) | 3.84129397 |
24 | protein deneddylation (GO:0000338) | 3.82850309 |
25 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.78798236 |
26 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.78798236 |
27 | RNA capping (GO:0036260) | 3.78427822 |
28 | 7-methylguanosine RNA capping (GO:0009452) | 3.78427822 |
29 | cullin deneddylation (GO:0010388) | 3.76563289 |
30 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.75537636 |
31 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.75537636 |
32 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.75537636 |
33 | 7-methylguanosine mRNA capping (GO:0006370) | 3.75431112 |
34 | viral transcription (GO:0019083) | 3.75004253 |
35 | ribosomal small subunit biogenesis (GO:0042274) | 3.73786422 |
36 | regulation of protein heterodimerization activity (GO:0043497) | 3.72419165 |
37 | translational termination (GO:0006415) | 3.69895072 |
38 | establishment of viral latency (GO:0019043) | 3.67451428 |
39 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.64852431 |
40 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.62009470 |
41 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.62009470 |
42 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.60485741 |
43 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.56402127 |
44 | ribosome assembly (GO:0042255) | 3.54487543 |
45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.50359657 |
46 | positive regulation of ligase activity (GO:0051351) | 3.49412386 |
47 | cotranslational protein targeting to membrane (GO:0006613) | 3.49233105 |
48 | maturation of SSU-rRNA (GO:0030490) | 3.48971122 |
49 | protein heterotetramerization (GO:0051290) | 3.48921587 |
50 | protein targeting to ER (GO:0045047) | 3.41326219 |
51 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41063974 |
52 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.35973260 |
53 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.35973260 |
54 | NADH dehydrogenase complex assembly (GO:0010257) | 3.35973260 |
55 | respiratory electron transport chain (GO:0022904) | 3.35817372 |
56 | COPI coating of Golgi vesicle (GO:0048205) | 3.35755620 |
57 | Golgi transport vesicle coating (GO:0048200) | 3.35755620 |
58 | protein targeting to mitochondrion (GO:0006626) | 3.35202122 |
59 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.34330618 |
60 | protein localization to endoplasmic reticulum (GO:0070972) | 3.31925608 |
61 | rRNA modification (GO:0000154) | 3.31115873 |
62 | translation (GO:0006412) | 3.30257768 |
63 | translational elongation (GO:0006414) | 3.29277509 |
64 | de novo protein folding (GO:0006458) | 3.29264633 |
65 | establishment of protein localization to mitochondrion (GO:0072655) | 3.28156399 |
66 | electron transport chain (GO:0022900) | 3.26755533 |
67 | sequestering of actin monomers (GO:0042989) | 3.23775380 |
68 | protein complex biogenesis (GO:0070271) | 3.23244558 |
69 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.22892894 |
70 | negative regulation of protein ubiquitination (GO:0031397) | 3.22578621 |
71 | ribosomal large subunit biogenesis (GO:0042273) | 3.21335263 |
72 | neutrophil activation involved in immune response (GO:0002283) | 3.20833148 |
73 | translational initiation (GO:0006413) | 3.20150961 |
74 | formation of translation preinitiation complex (GO:0001731) | 3.13068274 |
75 | mitotic metaphase plate congression (GO:0007080) | 3.11656095 |
76 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.11474017 |
77 | positive regulation of actin filament depolymerization (GO:0030836) | 3.08896696 |
78 | * antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.07372174 |
79 | DNA replication checkpoint (GO:0000076) | 3.05957072 |
80 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.05947222 |
81 | de novo posttranslational protein folding (GO:0051084) | 3.05096074 |
82 | viral life cycle (GO:0019058) | 3.04860987 |
83 | regulation of ligase activity (GO:0051340) | 3.04383985 |
84 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.03980171 |
85 | platelet dense granule organization (GO:0060155) | 3.03670784 |
86 | purine nucleotide salvage (GO:0032261) | 3.03615171 |
87 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.02605971 |
88 | protein localization to mitochondrion (GO:0070585) | 3.01029469 |
89 | cellular protein complex disassembly (GO:0043624) | 3.00313243 |
90 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.99589981 |
91 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.99314958 |
92 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.98615867 |
93 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.98587584 |
94 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.97470147 |
95 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.96669020 |
96 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.95703942 |
97 | positive regulation of cell cycle arrest (GO:0071158) | 2.94925646 |
98 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93522973 |
99 | cell cycle G1/S phase transition (GO:0044843) | 2.92731019 |
100 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.92731019 |
101 | regulation of cellular amine metabolic process (GO:0033238) | 2.92518720 |
102 | nuclear envelope reassembly (GO:0031468) | 2.92498849 |
103 | mitotic nuclear envelope reassembly (GO:0007084) | 2.92498849 |
104 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.91198063 |
105 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.89756577 |
106 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.88728613 |
107 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.88728613 |
108 | cellular component biogenesis (GO:0044085) | 2.87774534 |
109 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84615278 |
110 | CENP-A containing nucleosome assembly (GO:0034080) | 2.84001066 |
111 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.83575871 |
112 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.83575871 |
113 | regulation of cell cycle arrest (GO:0071156) | 2.83074687 |
114 | regulation of mitochondrial translation (GO:0070129) | 2.82831555 |
115 | cytochrome complex assembly (GO:0017004) | 2.82768970 |
116 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.81560361 |
117 | L-methionine salvage (GO:0071267) | 2.78829314 |
118 | L-methionine biosynthetic process (GO:0071265) | 2.78829314 |
119 | amino acid salvage (GO:0043102) | 2.78829314 |
120 | protein localization to kinetochore (GO:0034501) | 2.78716480 |
121 | DNA strand elongation (GO:0022616) | 2.78619770 |
122 | transcription from RNA polymerase I promoter (GO:0006360) | 2.77623126 |
123 | membrane budding (GO:0006900) | 2.76732902 |
124 | signal transduction in response to DNA damage (GO:0042770) | 2.76196118 |
125 | rRNA processing (GO:0006364) | 2.74541718 |
126 | transcription elongation from RNA polymerase II promoter (GO:0006368) | 2.73408085 |
127 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.73150441 |
128 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.72874936 |
129 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.72838549 |
130 | respiratory chain complex IV assembly (GO:0008535) | 2.72516010 |
131 | protein localization to chromosome, centromeric region (GO:0071459) | 2.70309605 |
132 | AMP metabolic process (GO:0046033) | 2.69735612 |
133 | positive regulation of protein ubiquitination (GO:0031398) | 2.69476794 |
134 | chromatin remodeling at centromere (GO:0031055) | 2.67341139 |
135 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.66144554 |
136 | ventricular cardiac muscle cell development (GO:0055015) | 2.65980685 |
137 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.65012373 |
138 | heart process (GO:0003015) | 2.64185290 |
139 | heart contraction (GO:0060047) | 2.64185290 |
140 | DNA damage response, detection of DNA damage (GO:0042769) | 2.58641970 |
141 | regulation of spindle organization (GO:0090224) | 2.57309628 |
142 | fatty acid elongation (GO:0030497) | 2.55826478 |
143 | positive regulation of protein modification by small protein conjugation or removal (GO:1903322) | 2.54664258 |
144 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.53209398 |
145 | natural killer cell mediated immunity (GO:0002228) | 2.53209398 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.59652048 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.42170939 |
3 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.04999335 |
4 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.84360684 |
5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.73844259 |
6 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.61015286 |
7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.55906722 |
8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.47051423 |
9 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.39462391 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.39367285 |
11 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.27019919 |
12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.06437157 |
13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.97896328 |
14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.92091008 |
15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.84609555 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.80302162 |
17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.76843876 |
18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.74986591 |
19 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.67399157 |
20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.66849493 |
21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.50910998 |
22 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.46719094 |
23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.37832676 |
24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.35847598 |
25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.29208465 |
26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.28508246 |
27 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.25617731 |
28 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.25409146 |
29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.25349053 |
30 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.14995521 |
31 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.14702912 |
32 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.09916682 |
33 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.07640505 |
34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.01185265 |
35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.01109221 |
36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.98569574 |
37 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.96843071 |
38 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.96214413 |
39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.95099823 |
40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93101945 |
41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.90722804 |
42 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.84802108 |
43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.83959616 |
44 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.77827242 |
45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77098765 |
46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.75960337 |
47 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.72141322 |
48 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65106933 |
49 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.62146429 |
50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.60950354 |
51 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.58650438 |
52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55961494 |
53 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.50772112 |
54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48769640 |
55 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.48162358 |
56 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.46777767 |
57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45835139 |
58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.45486678 |
59 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.44481990 |
60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.43980578 |
61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43584233 |
62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39423739 |
63 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.36609015 |
64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.36538971 |
65 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.24709770 |
66 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.17429642 |
67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16582199 |
68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.16319704 |
69 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16010194 |
70 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15744476 |
71 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15353194 |
72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12998446 |
73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12903810 |
74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.12584230 |
75 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11347654 |
76 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07404566 |
77 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.07364484 |
78 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.07015129 |
79 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.06677205 |
80 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06460760 |
81 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04581050 |
82 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.04351321 |
83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04215889 |
84 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.04177196 |
85 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.03766354 |
86 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03437752 |
87 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.03177740 |
88 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01767807 |
89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.98191983 |
90 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94874539 |
91 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.94337089 |
92 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.93888859 |
93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93516988 |
94 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93213802 |
95 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93051056 |
96 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93051056 |
97 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92360371 |
98 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91634362 |
99 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90993471 |
100 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.89963814 |
101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89857601 |
102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.86512435 |
103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.85257526 |
104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81100451 |
105 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.81036440 |
106 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79644327 |
107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79556039 |
108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.79507588 |
109 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78955266 |
110 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78572694 |
111 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76392860 |
112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.76025885 |
113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.75859539 |
114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.74463356 |
115 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.74412254 |
116 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.73927741 |
117 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73566093 |
118 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72825399 |
119 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.72243645 |
120 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.71691322 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.10602599 |
2 | MP0004957_abnormal_blastocyst_morpholog | 3.25613292 |
3 | MP0009785_altered_susceptibility_to | 2.93235214 |
4 | MP0002877_abnormal_melanocyte_morpholog | 2.79802982 |
5 | MP0002148_abnormal_hypersensitivity_rea | 2.79053364 |
6 | MP0001835_abnormal_antigen_presentation | 2.78092430 |
7 | MP0003186_abnormal_redox_activity | 2.62835929 |
8 | MP0003646_muscle_fatigue | 2.60863270 |
9 | MP0003136_yellow_coat_color | 2.53309353 |
10 | MP0003077_abnormal_cell_cycle | 2.40661201 |
11 | MP0008438_abnormal_cutaneous_collagen | 2.39628974 |
12 | MP0010094_abnormal_chromosome_stability | 2.37234470 |
13 | MP0003718_maternal_effect | 2.36399668 |
14 | MP0005671_abnormal_response_to | 2.31055171 |
15 | MP0005451_abnormal_body_composition | 2.22360667 |
16 | MP0009333_abnormal_splenocyte_physiolog | 2.21520117 |
17 | MP0003436_decreased_susceptibility_to | 2.19527199 |
18 | MP0008932_abnormal_embryonic_tissue | 2.19304851 |
19 | MP0005000_abnormal_immune_tolerance | 2.13670112 |
20 | MP0008260_abnormal_autophagy | 2.12996206 |
21 | MP0005084_abnormal_gallbladder_morpholo | 2.12692195 |
22 | MP0001986_abnormal_taste_sensitivity | 2.11313105 |
23 | MP0003724_increased_susceptibility_to | 2.10783433 |
24 | MP0003111_abnormal_nucleus_morphology | 2.04926881 |
25 | MP0005083_abnormal_biliary_tract | 2.03725446 |
26 | MP0008058_abnormal_DNA_repair | 2.03156047 |
27 | MP0003806_abnormal_nucleotide_metabolis | 1.98482800 |
28 | MP0002419_abnormal_innate_immunity | 1.95440144 |
29 | MP0005025_abnormal_response_to | 1.93276308 |
30 | MP0001529_abnormal_vocalization | 1.92611698 |
31 | MP0000372_irregular_coat_pigmentation | 1.88491220 |
32 | MP0006054_spinal_hemorrhage | 1.83448762 |
33 | MP0006036_abnormal_mitochondrial_physio | 1.79823292 |
34 | MP0000749_muscle_degeneration | 1.76899026 |
35 | MP0002452_abnormal_antigen_presenting | 1.74772148 |
36 | MP0005165_increased_susceptibility_to | 1.74695324 |
37 | MP0002723_abnormal_immune_serum | 1.73622710 |
38 | MP0006082_CNS_inflammation | 1.71921676 |
39 | MP0009379_abnormal_foot_pigmentation | 1.70678806 |
40 | MP0001800_abnormal_humoral_immune | 1.66765882 |
41 | MP0001819_abnormal_immune_cell | 1.62894912 |
42 | MP0002420_abnormal_adaptive_immunity | 1.62541265 |
43 | MP0008057_abnormal_DNA_replication | 1.59323820 |
44 | MP0001853_heart_inflammation | 1.57854816 |
45 | MP0010368_abnormal_lymphatic_system | 1.56752333 |
46 | MP0003566_abnormal_cell_adhesion | 1.53239749 |
47 | MP0005257_abnormal_intraocular_pressure | 1.51910277 |
48 | MP0005330_cardiomyopathy | 1.49628534 |
49 | MP0005501_abnormal_skin_physiology | 1.47339783 |
50 | MP0009053_abnormal_anal_canal | 1.46827787 |
51 | MP0008007_abnormal_cellular_replicative | 1.45824394 |
52 | MP0000343_altered_response_to | 1.45684329 |
53 | MP0000516_abnormal_urinary_system | 1.44271008 |
54 | MP0005367_renal/urinary_system_phenotyp | 1.44271008 |
55 | MP0003950_abnormal_plasma_membrane | 1.43328816 |
56 | MP0001542_abnormal_bone_strength | 1.42820300 |
57 | MP0005058_abnormal_lysosome_morphology | 1.42440113 |
58 | MP0001905_abnormal_dopamine_level | 1.38924608 |
59 | MP0002102_abnormal_ear_morphology | 1.37916488 |
60 | MP0008775_abnormal_heart_ventricle | 1.36972872 |
61 | MP0005623_abnormal_meninges_morphology | 1.36767309 |
62 | MP0001243_abnormal_dermal_layer | 1.36209679 |
63 | MP0002638_abnormal_pupillary_reflex | 1.35051167 |
64 | MP0006035_abnormal_mitochondrial_morpho | 1.34818026 |
65 | MP0002405_respiratory_system_inflammati | 1.34361255 |
66 | MP0005387_immune_system_phenotype | 1.32342797 |
67 | MP0001790_abnormal_immune_system | 1.32342797 |
68 | MP0002398_abnormal_bone_marrow | 1.32284191 |
69 | MP0003656_abnormal_erythrocyte_physiolo | 1.30781687 |
70 | MP0001879_abnormal_lymphatic_vessel | 1.27472529 |
71 | MP0000716_abnormal_immune_system | 1.26895891 |
72 | MP0000858_altered_metastatic_potential | 1.26247590 |
73 | MP0004782_abnormal_surfactant_physiolog | 1.25417621 |
74 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25360606 |
75 | MP0000490_abnormal_crypts_of | 1.23183471 |
76 | MP0002277_abnormal_respiratory_mucosa | 1.22868094 |
77 | MP0002163_abnormal_gland_morphology | 1.22652796 |
78 | MP0002735_abnormal_chemical_nociception | 1.22543240 |
79 | MP0005408_hypopigmentation | 1.21526433 |
80 | MP0000689_abnormal_spleen_morphology | 1.20794373 |
81 | MP0002132_abnormal_respiratory_system | 1.19788652 |
82 | MP0002396_abnormal_hematopoietic_system | 1.18415515 |
83 | MP0000685_abnormal_immune_system | 1.17093208 |
84 | MP0003763_abnormal_thymus_physiology | 1.16545260 |
85 | MP0001845_abnormal_inflammatory_respons | 1.16313471 |
86 | MP0002429_abnormal_blood_cell | 1.16145463 |
87 | MP0004084_abnormal_cardiac_muscle | 1.15935025 |
88 | MP0002722_abnormal_immune_system | 1.12104003 |
89 | MP0002736_abnormal_nociception_after | 1.08096257 |
90 | MP0003786_premature_aging | 1.07463291 |
91 | MP0004381_abnormal_hair_follicle | 1.06121541 |
92 | MP0010030_abnormal_orbit_morphology | 1.05937425 |
93 | MP0002972_abnormal_cardiac_muscle | 1.05868419 |
94 | MP0002060_abnormal_skin_morphology | 1.04594934 |
95 | MP0001533_abnormal_skeleton_physiology | 1.02030124 |
96 | MP0000015_abnormal_ear_pigmentation | 1.01827288 |
97 | MP0008469_abnormal_protein_level | 1.00424808 |
98 | MP0002796_impaired_skin_barrier | 0.99957801 |
99 | MP0002332_abnormal_exercise_endurance | 0.97731421 |
100 | MP0003191_abnormal_cellular_cholesterol | 0.97256455 |
101 | MP0000647_abnormal_sebaceous_gland | 0.97161517 |
102 | MP0000358_abnormal_cell_content/ | 0.96367153 |
103 | MP0002019_abnormal_tumor_incidence | 0.95751156 |
104 | MP0001881_abnormal_mammary_gland | 0.92521235 |
105 | MP0000750_abnormal_muscle_regeneration | 0.91956179 |
106 | MP0001697_abnormal_embryo_size | 0.90843410 |
107 | MP0009697_abnormal_copulation | 0.89492896 |
108 | MP0000313_abnormal_cell_death | 0.88298898 |
109 | MP0004233_abnormal_muscle_weight | 0.87950042 |
110 | MP0004215_abnormal_myocardial_fiber | 0.87608550 |
111 | MP0000350_abnormal_cell_proliferation | 0.86343496 |
112 | MP0001851_eye_inflammation | 0.85029178 |
113 | MP0010155_abnormal_intestine_physiology | 0.84992996 |
114 | MP0005464_abnormal_platelet_physiology | 0.83772017 |
115 | MP0002090_abnormal_vision | 0.83436893 |
116 | MP0001727_abnormal_embryo_implantation | 0.83399336 |
117 | MP0002177_abnormal_outer_ear | 0.81821841 |
118 | MP0004272_abnormal_basement_membrane | 0.81724816 |
119 | MP0005275_abnormal_skin_tensile | 0.81673383 |
120 | MP0003279_aneurysm | 0.80558012 |
121 | MP0005384_cellular_phenotype | 0.80002868 |
122 | MP0004947_skin_inflammation | 0.79981898 |
123 | MP0005397_hematopoietic_system_phenotyp | 0.79779249 |
124 | MP0001545_abnormal_hematopoietic_system | 0.79779249 |
125 | MP0004147_increased_porphyrin_level | 0.79372477 |
126 | MP0005164_abnormal_response_to | 0.78857315 |
127 | MP0001730_embryonic_growth_arrest | 0.77441393 |
128 | MP0000751_myopathy | 0.77259714 |
129 | MP0001968_abnormal_touch/_nociception | 0.77080914 |
130 | MP0003941_abnormal_skin_development | 0.76516673 |
131 | MP0004510_myositis | 0.76345807 |
132 | MP0009764_decreased_sensitivity_to | 0.76129893 |
133 | MP0005197_abnormal_uvea_morphology | 0.74759958 |
134 | MP0003448_altered_tumor_morphology | 0.74685546 |
135 | MP0000747_muscle_weakness | 0.74647382 |
136 | MP0006292_abnormal_olfactory_placode | 0.74139029 |
137 | MP0000427_abnormal_hair_cycle | 0.72443132 |
138 | MP0010352_gastrointestinal_tract_polyps | 0.71940421 |
139 | MP0003123_paternal_imprinting | 0.71344034 |
140 | MP0006276_abnormal_autonomic_nervous | 0.71106508 |
141 | MP0005266_abnormal_metabolism | 0.71057076 |
142 | MP0003011_delayed_dark_adaptation | 0.70843193 |
143 | MP0005075_abnormal_melanosome_morpholog | 0.69563505 |
144 | MP0000465_gastrointestinal_hemorrhage | 0.69384872 |
145 | MP0003303_peritoneal_inflammation | 0.69344223 |
146 | MP0003315_abnormal_perineum_morphology | 0.69047136 |
147 | MP0001188_hyperpigmentation | 0.68790539 |
148 | MP0005379_endocrine/exocrine_gland_phen | 0.68374889 |
149 | MP0001764_abnormal_homeostasis | 0.67875253 |
150 | * MP0002080_prenatal_lethality | 0.67239519 |
151 | MP0005621_abnormal_cell_physiology | 0.66163407 |
152 | MP0003828_pulmonary_edema | 0.61955427 |
153 | MP0001216_abnormal_epidermal_layer | 0.61681007 |
154 | MP0010771_integument_phenotype | 0.61623239 |
155 | MP0009763_increased_sensitivity_to | 0.60762779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 4.46349203 |
2 | Mitochondrial inheritance (HP:0001427) | 4.19504898 |
3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.96750531 |
4 | Hepatocellular necrosis (HP:0001404) | 3.91567424 |
5 | Recurrent abscess formation (HP:0002722) | 3.83921937 |
6 | Increased CSF lactate (HP:0002490) | 3.76967091 |
7 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.72887536 |
8 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.59926511 |
9 | Abnormal number of erythroid precursors (HP:0012131) | 3.54656373 |
10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.54018299 |
11 | Progressive macrocephaly (HP:0004481) | 3.51198875 |
12 | Hepatic necrosis (HP:0002605) | 3.50569067 |
13 | Acute encephalopathy (HP:0006846) | 3.49982830 |
14 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.45441412 |
15 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.39599446 |
16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.39599446 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.38790875 |
18 | Increased serum pyruvate (HP:0003542) | 3.36167649 |
19 | Abnormality of glycolysis (HP:0004366) | 3.36167649 |
20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.33524912 |
21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.24074649 |
22 | Exertional dyspnea (HP:0002875) | 3.19215875 |
23 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.14544402 |
24 | Reduced subcutaneous adipose tissue (HP:0003758) | 3.14387753 |
25 | Lipid accumulation in hepatocytes (HP:0006561) | 3.06176066 |
26 | Reticulocytopenia (HP:0001896) | 3.06055859 |
27 | Renal Fanconi syndrome (HP:0001994) | 2.98356480 |
28 | Cerebral hypomyelination (HP:0006808) | 2.96303720 |
29 | Eczematoid dermatitis (HP:0000976) | 2.96037438 |
30 | Increased serum lactate (HP:0002151) | 2.93255753 |
31 | Breast hypoplasia (HP:0003187) | 2.92506131 |
32 | Birth length less than 3rd percentile (HP:0003561) | 2.89647300 |
33 | Limb-girdle muscle atrophy (HP:0003797) | 2.77746077 |
34 | Premature rupture of membranes (HP:0001788) | 2.76166413 |
35 | Aplastic anemia (HP:0001915) | 2.74533306 |
36 | Poor head control (HP:0002421) | 2.73675300 |
37 | Abnormality of the anterior horn cell (HP:0006802) | 2.70241755 |
38 | Degeneration of anterior horn cells (HP:0002398) | 2.70241755 |
39 | Macrocytic anemia (HP:0001972) | 2.70238786 |
40 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.66766180 |
41 | Carpal bone hypoplasia (HP:0001498) | 2.66042596 |
42 | Parakeratosis (HP:0001036) | 2.65570128 |
43 | Respiratory failure (HP:0002878) | 2.61573267 |
44 | Type I transferrin isoform profile (HP:0003642) | 2.58655060 |
45 | Autoamputation (HP:0001218) | 2.56896753 |
46 | Abnormality of macrophages (HP:0004311) | 2.54129195 |
47 | Exercise intolerance (HP:0003546) | 2.52606508 |
48 | Respiratory difficulties (HP:0002880) | 2.51781869 |
49 | Lactic acidosis (HP:0003128) | 2.47084800 |
50 | Fasciculations (HP:0002380) | 2.45719701 |
51 | Increased intramyocellular lipid droplets (HP:0012240) | 2.43424969 |
52 | Pallor (HP:0000980) | 2.41583901 |
53 | Amyotrophic lateral sclerosis (HP:0007354) | 2.41563408 |
54 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.41147286 |
55 | Agnosia (HP:0010524) | 2.39307526 |
56 | Shoulder girdle muscle weakness (HP:0003547) | 2.39086706 |
57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.36713481 |
58 | Obstructive lung disease (HP:0006536) | 2.36713481 |
59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.34621775 |
60 | Hand muscle atrophy (HP:0009130) | 2.33587215 |
61 | Rough bone trabeculation (HP:0100670) | 2.33556719 |
62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.33179166 |
63 | Generalized aminoaciduria (HP:0002909) | 2.29773784 |
64 | Abnormality of glycolipid metabolism (HP:0010969) | 2.28346816 |
65 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.28346816 |
66 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.28346816 |
67 | Irregular epiphyses (HP:0010582) | 2.27540105 |
68 | Oral leukoplakia (HP:0002745) | 2.26393402 |
69 | Increased IgM level (HP:0003496) | 2.25270570 |
70 | Vertebral compression fractures (HP:0002953) | 2.22366616 |
71 | Upper motor neuron abnormality (HP:0002127) | 2.19447725 |
72 | Microretrognathia (HP:0000308) | 2.18214797 |
73 | Multiple enchondromatosis (HP:0005701) | 2.18187245 |
74 | Leukodystrophy (HP:0002415) | 2.17413155 |
75 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.15195647 |
76 | Opisthotonus (HP:0002179) | 2.12914328 |
77 | Nausea (HP:0002018) | 2.11989551 |
78 | Delayed gross motor development (HP:0002194) | 2.07571321 |
79 | Abnormality of the umbilical cord (HP:0010881) | 2.06350504 |
80 | Axonal loss (HP:0003447) | 2.04682289 |
81 | Cerebral edema (HP:0002181) | 2.04085696 |
82 | Mediastinal lymphadenopathy (HP:0100721) | 2.03972913 |
83 | Vacuolated lymphocytes (HP:0001922) | 2.03292947 |
84 | X-linked dominant inheritance (HP:0001423) | 2.01683582 |
85 | Abnormal gallbladder physiology (HP:0012438) | 2.01585844 |
86 | Cholecystitis (HP:0001082) | 2.01585844 |
87 | Congenital, generalized hypertrichosis (HP:0004540) | 2.01508188 |
88 | Hepatosplenomegaly (HP:0001433) | 2.01021108 |
89 | Palpitations (HP:0001962) | 2.00993325 |
90 | Myositis (HP:0100614) | 1.99726928 |
91 | Petechiae (HP:0000967) | 1.99297185 |
92 | Optic disc pallor (HP:0000543) | 1.98689547 |
93 | Abnormality of the motor neurons (HP:0002450) | 1.96432412 |
94 | Abnormal neuron morphology (HP:0012757) | 1.96432412 |
95 | Retinal dysplasia (HP:0007973) | 1.96144262 |
96 | Exercise-induced muscle cramps (HP:0003710) | 1.95577737 |
97 | Increased muscle lipid content (HP:0009058) | 1.95207475 |
98 | Achilles tendon contracture (HP:0001771) | 1.94339271 |
99 | Premature graying of hair (HP:0002216) | 1.93790540 |
100 | CNS demyelination (HP:0007305) | 1.93337226 |
101 | Reduced antithrombin III activity (HP:0001976) | 1.93182827 |
102 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.92753287 |
103 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.92753287 |
104 | Upper limb muscle weakness (HP:0003484) | 1.92069290 |
105 | Premature ovarian failure (HP:0008209) | 1.91430860 |
106 | Distal lower limb muscle weakness (HP:0009053) | 1.90902253 |
107 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.89988329 |
108 | Abnormal trabecular bone morphology (HP:0100671) | 1.89843098 |
109 | Stenosis of the external auditory canal (HP:0000402) | 1.88458627 |
110 | Cleft eyelid (HP:0000625) | 1.88187044 |
111 | IgM deficiency (HP:0002850) | 1.88006209 |
112 | Nemaline bodies (HP:0003798) | 1.86086571 |
113 | Postnatal microcephaly (HP:0005484) | 1.85965984 |
114 | Amniotic constriction ring (HP:0009775) | 1.85733348 |
115 | Abnormality of placental membranes (HP:0011409) | 1.85733348 |
116 | Pulmonary fibrosis (HP:0002206) | 1.85222416 |
117 | Fatigue (HP:0012378) | 1.85154195 |
118 | Recurrent skin infections (HP:0001581) | 1.84668422 |
119 | Hypokinesia (HP:0002375) | 1.84154856 |
120 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.83972371 |
121 | Abnormal protein glycosylation (HP:0012346) | 1.83972371 |
122 | Abnormal glycosylation (HP:0012345) | 1.83972371 |
123 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.83972371 |
124 | Retrobulbar optic neuritis (HP:0100654) | 1.83066508 |
125 | Optic neuritis (HP:0100653) | 1.83066508 |
126 | CNS hypomyelination (HP:0003429) | 1.81947373 |
127 | Spastic paraparesis (HP:0002313) | 1.81651876 |
128 | Mucosal telangiectasiae (HP:0100579) | 1.81432606 |
129 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.81266017 |
130 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.81046919 |
131 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.80840915 |
132 | Single umbilical artery (HP:0001195) | 1.80840915 |
133 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.80840915 |
134 | Follicular hyperkeratosis (HP:0007502) | 1.80613603 |
135 | Sparse eyelashes (HP:0000653) | 1.80541927 |
136 | Distal upper limb amyotrophy (HP:0007149) | 1.80415558 |
137 | Upper limb amyotrophy (HP:0009129) | 1.80415558 |
138 | Adrenal hypoplasia (HP:0000835) | 1.79496764 |
139 | Orthostatic hypotension (HP:0001278) | 1.79364827 |
140 | Patellar aplasia (HP:0006443) | 1.78763897 |
141 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.78651681 |
142 | Abnormality of alanine metabolism (HP:0010916) | 1.78651681 |
143 | Hyperalaninemia (HP:0003348) | 1.78651681 |
144 | Pelvic girdle muscle weakness (HP:0003749) | 1.78076345 |
145 | Abnormality of renal resorption (HP:0011038) | 1.78026151 |
146 | Stomatitis (HP:0010280) | 1.75227434 |
147 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.74875663 |
148 | Secondary amenorrhea (HP:0000869) | 1.74700436 |
149 | Pancytopenia (HP:0001876) | 1.74632702 |
150 | Cutaneous photosensitivity (HP:0000992) | 1.74258742 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BUB1 | 3.67553895 |
2 | NME2 | 3.46478264 |
3 | EIF2AK1 | 3.38197779 |
4 | ARAF | 3.30298933 |
5 | PIM2 | 2.76367702 |
6 | VRK2 | 2.65415167 |
7 | WEE1 | 2.62827257 |
8 | MAP3K12 | 2.57043573 |
9 | STK16 | 2.51956092 |
10 | MST4 | 2.45462496 |
11 | TESK2 | 2.30511752 |
12 | TRIM28 | 2.18411165 |
13 | EIF2AK3 | 2.08817492 |
14 | VRK1 | 2.06561738 |
15 | PDK2 | 1.99986767 |
16 | PBK | 1.99533940 |
17 | PLK4 | 1.97636173 |
18 | RIPK4 | 1.93108052 |
19 | BRAF | 1.88356060 |
20 | BRSK2 | 1.88232627 |
21 | PAK4 | 1.86317556 |
22 | BLK | 1.82914513 |
23 | MAP3K14 | 1.69258787 |
24 | LIMK1 | 1.67077224 |
25 | SRPK1 | 1.45193845 |
26 | ERBB3 | 1.45146120 |
27 | TLK1 | 1.44787634 |
28 | EPHB2 | 1.38556410 |
29 | BCKDK | 1.36521408 |
30 | NME1 | 1.36049112 |
31 | SCYL2 | 1.34467571 |
32 | IRAK4 | 1.28265797 |
33 | ABL2 | 1.27049913 |
34 | TESK1 | 1.24601575 |
35 | SIK3 | 1.24218764 |
36 | PNCK | 1.23303213 |
37 | BMPR2 | 1.20184388 |
38 | CDK19 | 1.17002739 |
39 | IRAK3 | 1.15181257 |
40 | TSSK6 | 1.11932430 |
41 | CCNB1 | 1.11112462 |
42 | EIF2AK2 | 1.09771749 |
43 | NEK9 | 1.08477231 |
44 | PLK3 | 1.08327329 |
45 | TXK | 1.08243613 |
46 | GRK5 | 1.07630878 |
47 | EPHA2 | 1.07079858 |
48 | ACVR1B | 1.06615269 |
49 | PLK1 | 1.01312383 |
50 | AURKA | 1.00089081 |
51 | IKBKB | 0.99787245 |
52 | BRSK1 | 0.98829215 |
53 | RPS6KA4 | 0.98319091 |
54 | DYRK2 | 0.97838541 |
55 | MAP3K11 | 0.96869273 |
56 | TEC | 0.93340400 |
57 | ERBB4 | 0.93150976 |
58 | CDK8 | 0.91537907 |
59 | BCR | 0.90710123 |
60 | TBK1 | 0.90516498 |
61 | MKNK1 | 0.90422741 |
62 | MARK3 | 0.89958554 |
63 | TYK2 | 0.85651714 |
64 | NUAK1 | 0.84472564 |
65 | GRK7 | 0.84044347 |
66 | EPHB1 | 0.83619145 |
67 | RAF1 | 0.82901689 |
68 | STK24 | 0.82676454 |
69 | MYLK | 0.79004704 |
70 | MST1R | 0.77971558 |
71 | YES1 | 0.74845813 |
72 | STK3 | 0.74741639 |
73 | TAF1 | 0.74324388 |
74 | DAPK1 | 0.74268908 |
75 | SYK | 0.72893120 |
76 | CSNK1G3 | 0.72330865 |
77 | DMPK | 0.71720190 |
78 | MKNK2 | 0.71393416 |
79 | CLK1 | 0.71072995 |
80 | KDR | 0.70888376 |
81 | PLK2 | 0.70095694 |
82 | CDC7 | 0.69751945 |
83 | STK10 | 0.69560751 |
84 | NEK2 | 0.69356906 |
85 | MET | 0.68879577 |
86 | TTK | 0.68759169 |
87 | PIM1 | 0.68507030 |
88 | PAK1 | 0.67835811 |
89 | CDK18 | 0.66548710 |
90 | CSNK1A1L | 0.65175978 |
91 | ZAP70 | 0.64313741 |
92 | MOS | 0.64030376 |
93 | CSNK1G2 | 0.63790510 |
94 | JAK3 | 0.62721127 |
95 | CASK | 0.61371205 |
96 | CSNK2A1 | 0.61263711 |
97 | KSR1 | 0.61214214 |
98 | NEK1 | 0.61144041 |
99 | LYN | 0.58522370 |
100 | AURKB | 0.56949059 |
101 | ZAK | 0.56613799 |
102 | KIT | 0.56521018 |
103 | CDK11A | 0.56420679 |
104 | CDK15 | 0.55989026 |
105 | IKBKE | 0.55181940 |
106 | NLK | 0.53756690 |
107 | MAP4K1 | 0.52010673 |
108 | CDK6 | 0.51823221 |
109 | MAP3K5 | 0.51007652 |
110 | ILK | 0.50967041 |
111 | DAPK3 | 0.50932635 |
112 | STK38L | 0.50828663 |
113 | MAP3K8 | 0.50110297 |
114 | CDK7 | 0.50092167 |
115 | MAP3K13 | 0.48368679 |
116 | DYRK3 | 0.48199752 |
117 | ADRBK2 | 0.45850163 |
118 | MAP2K7 | 0.43811689 |
119 | BTK | 0.43586007 |
120 | MUSK | 0.43099396 |
121 | PRKCD | 0.43025353 |
122 | TRPM7 | 0.42273710 |
123 | MAP3K3 | 0.41935939 |
124 | STK39 | 0.41693420 |
125 | RPS6KA5 | 0.41453288 |
126 | PIK3CA | 0.40539304 |
127 | CHEK2 | 0.39527058 |
128 | CSNK2A2 | 0.38265197 |
129 | PTK2 | 0.38135780 |
130 | MAPKAPK5 | 0.35786202 |
131 | CDK14 | 0.35494430 |
132 | LRRK2 | 0.34966196 |
133 | CDK9 | 0.33313297 |
134 | ATR | 0.32789869 |
135 | STK4 | 0.32109503 |
136 | PRKCI | 0.31738784 |
137 | CSNK1G1 | 0.31540329 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 5.01285809 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.24347069 |
3 | RNA polymerase_Homo sapiens_hsa03020 | 3.77311598 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.57910140 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.07327365 |
6 | DNA replication_Homo sapiens_hsa03030 | 2.87420157 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.49520161 |
8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38162018 |
9 | Protein export_Homo sapiens_hsa03060 | 2.33949824 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30944105 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.30688109 |
12 | Mismatch repair_Homo sapiens_hsa03430 | 2.24083244 |
13 | Homologous recombination_Homo sapiens_hsa03440 | 2.13804984 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09403250 |
15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02998712 |
16 | Spliceosome_Homo sapiens_hsa03040 | 1.91142151 |
17 | Base excision repair_Homo sapiens_hsa03410 | 1.88367653 |
18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.88298692 |
19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.83915157 |
20 | RNA transport_Homo sapiens_hsa03013 | 1.55018602 |
21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40709354 |
22 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34526005 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.32617326 |
24 | Cell cycle_Homo sapiens_hsa04110 | 1.26919480 |
25 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26377215 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25765858 |
27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21222472 |
28 | RNA degradation_Homo sapiens_hsa03018 | 1.21160544 |
29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.19736928 |
30 | Purine metabolism_Homo sapiens_hsa00230 | 1.17934202 |
31 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.16314856 |
32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.12921275 |
33 | Asthma_Homo sapiens_hsa05310 | 1.08547720 |
34 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08437642 |
35 | Allograft rejection_Homo sapiens_hsa05330 | 1.08199028 |
36 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.07800478 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.02900180 |
38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.02263658 |
39 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.02220988 |
40 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.01919532 |
41 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99342082 |
42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97371209 |
43 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95687356 |
44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95466335 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94838635 |
46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93695035 |
47 | Leishmaniasis_Homo sapiens_hsa05140 | 0.93425355 |
48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.88569652 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.87881918 |
50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86902556 |
51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.84235135 |
52 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79840462 |
53 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79193918 |
54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78979958 |
55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.76086674 |
56 | Pertussis_Homo sapiens_hsa05133 | 0.74864580 |
57 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74729268 |
58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.72859666 |
59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72742718 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72329879 |
61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.72319832 |
62 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.72009599 |
63 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71604373 |
64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71109985 |
65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70861839 |
66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.70834168 |
67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69281668 |
68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.68349852 |
69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67359473 |
70 | Salmonella infection_Homo sapiens_hsa05132 | 0.65437183 |
71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65228196 |
72 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64309930 |
73 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.64029070 |
74 | Tuberculosis_Homo sapiens_hsa05152 | 0.63974667 |
75 | Bladder cancer_Homo sapiens_hsa05219 | 0.63385989 |
76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63145325 |
77 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.61657689 |
78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.61316037 |
79 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.60774858 |
80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.60109471 |
81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58147756 |
82 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57909421 |
83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56585373 |
84 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53738496 |
85 | Malaria_Homo sapiens_hsa05144 | 0.53543284 |
86 | Measles_Homo sapiens_hsa05162 | 0.52992609 |
87 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51496637 |
88 | Apoptosis_Homo sapiens_hsa04210 | 0.51473123 |
89 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.51049173 |
90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48546435 |
91 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47831787 |
92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.46785974 |
93 | Lysosome_Homo sapiens_hsa04142 | 0.46220619 |
94 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45912176 |
95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.45194278 |
96 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.44103138 |
97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.43752321 |
98 | Influenza A_Homo sapiens_hsa05164 | 0.43563734 |
99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43527587 |
100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36416020 |
101 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35861521 |
102 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35408938 |
103 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33789890 |
104 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.33765137 |
105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33628294 |
106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.32233606 |
107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.29035657 |
108 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.28182341 |
109 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26818355 |
110 | Hepatitis B_Homo sapiens_hsa05161 | 0.26327445 |
111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.24315582 |
112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.23929184 |
113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.23166455 |
114 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.21839821 |
115 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20588741 |
116 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17920141 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.17854040 |
118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.17852724 |
119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.15991364 |
120 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.15983701 |
121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15254868 |
122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.14771936 |